Achieve Life Sciences Inc. (NASDAQ: ACHV) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ACHIEVE LIFE SCIENCES INC.

Achieve Life Sciences Inc. (NASDAQ: ACHV)
Listen to this Section


$5.01
-0.2790 ( -5.27% ) 299.0K

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Clinical Trial Pipeline Stages


Drug Name Stage
CytisiniclineDetailsSmoking cessation Phase 3

Market Data


Open $5.01
Previous Close $5.29
Volume 299.0K
Market Cap $505.08M
Day Range $4.98 - $5.28
52 Week Range $2.00 - $6.15
Shares Outstanding 102.66M
Change % -5.27%
Net Change ▼ -0.2790
Insider Ownership -0.08%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
IPO Year1995
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -630,375.00

Date Type Amount Purchased Purchaser
2024-04-23 Sale -5625.00 Wan Jerry
2024-04-23 Sale -25000.00 Bencich John
2024-04-23 Sale -22500.00 Stewart Richard Alistair
2024-04-23 Sale -16250.00 JACOBS CINDY
2024-03-06 Buy 10000.00 Bencich John
2024-03-06 Buy 10000.00 Stewart Richard Alistair
2024-01-29 Sale -31500.00 Martell Bridget A
2024-01-24 Sale -84000.00 JACOBS CINDY
2024-01-24 Sale -140000.00 Stewart Richard Alistair
2024-01-24 Sale -24500.00 Wan Jerry

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 10, 2025
4 Insider transactions 1 Jun 10, 2025
4 Insider transactions 1 Jun 10, 2025
4 Insider transactions 1 Jun 10, 2025
8-k 8K-related 10 Jun 06, 2025

Latest News


× Before browsing our site, please accept our cookies policy